Agoracom Blog

CLIENT FEATURE: Hollister Biosciences $ $HSTRF Hits All-Time High, Wholly Owned Subsidiary Venom Extracts Achieves $40 Million Revenue Milestone $CRON $GTBIF $INDS $ $ $

Posted by AGORACOM-JC at 3:38 PM on Friday, December 11th, 2020

Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success: 


  • Q1  $1,200,000
  • Q2  $11,500,000
  • Q3  $12,500,000

NOTE: Venom Extracts Acquisition Closed at the end of Q1.


  • REVENUE  $25.2M

On December 9 th, 2020, Venom achieved the second and final revenue milestone by generating in excess of CDN$40,000,000 of revenue calculated from January 1 st, 2020.

With the recent passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona Hollister is extremely well positioned to capitalize. This can best be summed up by quote of Venom Extracts Founder below:

“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen, Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona

In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , , , , , ,

Comments are closed.